To further explore the effect of TPD52L2 expression and immune activity in TME, we analyzed the infiltration abundance of 22 immune cell species in ccRCC-TME using the CIBERSORT algorithm. The gene discussed is TPD52L2; the disease is nonpapillary renal cell carcinoma.